References
- HasanAFalkaiPWobrockTWFSBP Task Force on Treatment Guidelines for SchizophreniaWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effectsWorld J Biol Psychiatry201314124423216388
- ABILIFY® (aripiprazole) [prescribing information]TokyoOtsuka Pharmaceutical Co., Ltd2016
- MallikaarjunSSalazarDEBramerSLPharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteersJ Clin Pharmacol200444217918714747427
- Center for Drug Evaluation and ResearchApplication Number: 202971Orig1s000 Clinical Pharmacology and Biopharmaceutics Review(s)Silver SpringFood and Drug Administration2011
- Abilify Maintena® US (aripiprazole) [prescribing information]TokyoOtsuka Pharmaceutical Co., Ltd2016
- Aristada® (aripiprazole lauroxil) [prescribing information]WalthamAlkermes, Inc2016
- RohdeMM RkNHåkanssonAEBiological conversion of aripiprazole lauroxil – an N-acyloxymethyl aripiprazole prodrugResults Pharma Sci20144192525756003
- HiemkeCBaumannPBergemannNAGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011Pharmacopsychiatry2011446195235
- RaoufiniaAPeters-StricklandTNylanderAGAripiprazole once-monthly 400 mg: comparison of pharmacokinetics, tolerability, and safety of deltoid versus gluteal administrationInt J Neuropsychopharmacol Epub2017215
- MallikaarjunSKaneJMBricmontPPharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: an open-label, parallel-arm, multiple-dose studySchizophr Res2013150128128823890595
- MouldDRUptonRNBasic concepts in population modeling, simulation, and model-based drug developmentCPT Pharmacometrics Syst Pharmacol20121e623835886
- FleischhackerWWSanchezRPerryPPAripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority studyBr J Psychiatry2014205213514424925984
- KaneJMSanchezRPerryPPAripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled studyJ Clin Psychiatry201273561762422697189
- Center for Drug Evaluation and ResearchApplication Number: 207533Orig1s000 Clinical Pharmacology and Biopharmaceutics Review(s) (Addendum to PBPK, Pharmacometric, Clin Pharm Reviews and Clin Pharm Addendum) and Pharmacometric ReviewSilver SpringFood and Drug Administration2015
- MeltzerHYRisingerRNasrallahHAA randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophreniaJ Clin Psychiatry20157681085109026114240